glp 1 microdosing uk Scientists say there is no link between 'microdosing' weight-loss drugs and living longer Have you heard of microdosing

Remember that managing Hashimoto's effectively requires a collaborative, evidence-based approachand your healthcare team is best placed to guide safe, appropriate treatment decisions tailored to your individual circumstances

There are no legitimate long-term data to support it

Jeffrey Egler, Nooms Chief Medical Officer, puts it, lower dose does not mean lower responsibility. In fact, because microdosing requires slower, more deliberate titration, it often demands more oversight than the standard protocol

Microdosing GLP-1 means using doses significantly below the approved therapeutic range, but this practice lacks clinical trial evidence and is not approved by the MHRA

Patients should seek urgent medical attention if they experience severe persistent abdominal pain (which may indicate pancreatitis), persistent vomiting/dehydration, jaundice, acute visual changes, or hypoglycaemia if on insulin or sulfonylureas

K., Tso, S